產(chǎn)品名稱 | 畸胎瘤衍化生長(zhǎng)因子抗體(N端) |
英文名稱 | Anti-CRIPTO |
規(guī)格 | 0.2ml/200μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-CRIPTO
中文名稱 畸胎瘤衍化生長(zhǎng)因子抗體(N端)
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類型 一抗
研究領(lǐng)域 腫瘤 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子
蛋白分子量 predicted molecular weight: 13kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from humanTeratocarcinoma-derived growth factor 1
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -20 °C for one year.
別 名 CRIPTO; CRIPT; CR; CRGF; Cripto 1; Cripto-1; Cripto 1growth factor; Cripto-1 growth factor; Cripto1; Cripto1 growth factor;Epidermal growth factor like cripto protein CR1; Epidermal growth factor-likecripto protein CR1; TDGF 1; TDGF-1; TDGF1; Teratocarcinoma derived growthfactor 1; Teratocarcinoma-derived growth factor 1; teratocarcinoma-derivedgrowth factor 1 isoform 1 precursor; TDGF1_HUMAN.
